Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review
Xin Li, Yongcheng Song
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115772-115772
Open Access | Times Cited: 52

Showing 26-50 of 52 citing articles:

Xiaoer niuhuang qingxin powder alleviates influenza a virus infection by inhibiting the activation of the TLR4/MyD88/NF-κB signaling pathway
Lanying Ma, Tong Wang, Meiyi Liu, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 118000-118000
Closed Access | Times Cited: 1
Novel compounds with dual inhibition activity against SARS-CoV-2 critical enzymes RdRp and human TMPRSS2
Sameh S. M. Soliman, Alshaimaa M. Hamoda, Yogendra Nayak, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116671-116671
Closed Access | Times Cited: 1
Lessons learnt from broad-spectrum coronavirus antiviral drug discovery
Andrew A. Bolinger, Jun Li, Xuping Xie, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1023-1041
Closed Access | Times Cited: 1
Recent discovery of natural substances with cathepsin L-inhibitory activity for cancer metastasis suppression
Jun-Young Park, Kyung‐Min Park
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116754-116754
Closed Access | Times Cited: 1
How many organic small molecules might be used to treat COVID-19? From natural products to synthetic agents
Zai‐Qun Liu
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116788-116788
Closed Access | Times Cited: 1
Structural basis of main proteases of coronavirus bound to Bofutrelvir
Weiwei Wang, Pei Zeng, Tongchao Liu, et al.
Journal of Molecular Biology (2024) Vol. 436, Iss. 22, pp. 168784-168784
Closed Access | Times Cited: 1
High-throughput modular click chemistry synthesis of catechol derivatives as covalent inhibitors of SARS-CoV-2 3CLpro
Feng Wang, Tiancheng Ma, Donglan Liu, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 1
Perspective for Drug Discovery Targeting SARS Coronavirus Methyltransferases: Function, Structure and Inhibition
Xin Li, Yongcheng Song
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 18642-18655
Closed Access | Times Cited: 1
Covalent ligands of nuclear receptors
S. S. Rajan, Ho Sup Yoon
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115869-115869
Closed Access | Times Cited: 3
Thermal, photonic, and electrocatalysis in lignin depolymerization research
Ziwei Wang, Shu Hao, Yizhen Chen, et al.
RSC Advances (2023) Vol. 13, Iss. 46, pp. 32627-32640
Open Access | Times Cited: 2
An isothermal calorimetry assay for determining steady state kinetic and enzyme inhibition parameters for SARS-CoV-2 3CL-protease
Luca Mazzei, Sofia Ranieri, Rebecca Greene-Cramer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Exploring multiple reaction pathways in the proteolysis of SARS-CoV-2 main protease through large-scale quantum molecular dynamics
Junichi Ono, Uika Koshimizu, Yoshifumi Fukunishi, et al.
Research Square (Research Square) (2024)
Open Access
Expression and Purification of SARS-CoV-2 Main Protease and Study of Novel Crystal Structure
雪静 刘
Hans Journal of Biomedicine (2024) Vol. 14, Iss. 02, pp. 229-239
Closed Access
Generative Adversarial Network (Gan) Model-Based Design of Potent Sars-Cov-2 Mpro Inhibitors Using the Electron Density of Ligands and 3d Binding Pockets: Insights from Molecular Docking, Dynamics Simulation, and Mm-Gbsa Analysis
Annesha Chakraborty, Vignesh Krishnan, Subbiah Thamotharan
(2024)
Closed Access
Breaking the Chain: Protease Inhibitors as Game Changers in Respiratory Viruses Management
Christos Papaneophytou
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8105-8105
Open Access
Antibacterial Potentials of Blumea balsamifera L. Essential Oil Against Streptococcus Pyogenes and Streptococcus Pneumoniae: In Vitro and In Silico Screening

Tropical Journal of Natural Product Research (2024) Vol. 8, Iss. 7
Open Access
Diosmetin-7-O-β-D-glucopyranoside from Pogostemonis Herba alleviated SARS-CoV-2-induced pneumonia by reshaping macrophage polarization and limiting viral replication
Yunlu Xu, Xuejian Li, Wei Cai, et al.
Journal of Ethnopharmacology (2024) Vol. 336, pp. 118704-118704
Closed Access
Discovery of a Nasal Spray Steroid, Tixocortol, as an Inhibitor of SARS-CoV-2 Main Protease and Viral Replication
David A. Davis, Ashwin Nair, Yana Astter, et al.
RSC Medicinal Chemistry (2024)
Closed Access
ClickGen: Directed exploration of synthesizable chemical space via modular reactions and reinforcement learning
Mingyang Wang, Shuai Li, Jike Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Backstage Heroes—Yeast in COVID-19 Research
Wojciech Grabiński, Andonis Karachitos, Anna Kicińska
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12661-12661
Open Access
Generative adversarial network (GAN) model-based design of potent SARS-CoV-2 Mpro inhibitors using the electron density of ligands and 3D binding pockets: insights from molecular docking, dynamics simulation, and MM-GBSA analysis
Annesha Chakraborty, Vignesh Krishnan, Subbiah Thamotharan
Molecular Diversity (2024)
Closed Access
An isothermal calorimetry assay for determining steady state kinetic and Ensitrelvir inhibition parameters for SARS-CoV-2 3CL-protease
Luca Mazzei, Sofia Ranieri, Davide Silvestri, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Molecular Modeling Strategies in Drug Design, Development, and Discovery Targeting Proteases
Viviane Corrêa Santos, Lucas Abreu Diniz, Rafaela Salgado Ferreira
(2024), pp. 435-461
Closed Access
In vitro anti-severe acute respiratory syndrome coronavirus 2 effect of Ephedra przewalskii Stapf extract
Masaki Kakimoto, Toshihito Nomura, Tanuza Nazmul, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117341-117341
Open Access | Times Cited: 1
In vitro anticancer evaluation of Enceleamycin A and its underlying mechanism
Abujunaid Khan, Sushma Pradeep, Syed G. Dastager
RSC Advances (2023) Vol. 13, Iss. 48, pp. 34183-34193
Open Access | Times Cited: 1

Scroll to top